| Literature DB >> 31534046 |
Blandine Monel1, Maaran Michael Rajah2,3, Mohamed Lamine Hafirassou4, Samy Sid Ahmed2, Julien Burlaud-Gaillard5, Peng-Peng Zhu6, Quentin Nevers2, Julian Buchrieser2, Françoise Porrot2, Cécile Meunier2, Sonia Amraoui2, Maxime Chazal7, Audrey Salles8, Nolwenn Jouvenet7, Philippe Roingeard5, Craig Blackstone6, Ali Amara4, Olivier Schwartz1.
Abstract
The endoplasmic reticulum (ER) is the site for Zika virus (ZIKV) replication and is central to the cytopathic effects observed in infected cells. ZIKV induces the formation of ER-derived large cytoplasmic vacuoles followed by "implosive" cell death. Little is known about the nature of the ER factors that regulate flavivirus replication. Atlastins (ATL1, -2, and -3) are dynamin-related GTPases that control the structure and the dynamics of the ER membrane. We show here that ZIKV replication is significantly decreased in the absence of ATL proteins. The appearance of infected cells is delayed, the levels of intracellular viral proteins and released virus are reduced, and the cytopathic effects are strongly impaired. We further show that ATL3 is recruited to viral replication sites and interacts with the nonstructural viral proteins NS2A and NS2B3. Thus, proteins that shape and maintain the ER tubular network ensure efficient ZIKV replication.IMPORTANCE Zika virus (ZIKV) is an emerging virus associated with Guillain-Barré syndrome, and fetal microcephaly as well as other neurological complications. There is no vaccine or specific antiviral treatment against ZIKV. We found that endoplasmic reticulum (ER)-shaping atlastin proteins (ATL1, -2, and -3), which induce ER membrane fusion, facilitate ZIKV replication. We show that ATL3 is recruited to the viral replication site and colocalize with the viral proteins NS2A and NS2B3. The results provide insights into host factors used by ZIKV to enhance its replication.Entities:
Keywords: Zika; atlastin; endoplasmic reticulum
Mesh:
Substances:
Year: 2019 PMID: 31534046 PMCID: PMC6854498 DOI: 10.1128/JVI.01047-19
Source DB: PubMed Journal: J Virol ISSN: 0022-538X Impact factor: 5.103